• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[用于激素受体测定的钻取活检和穿刺活检]

[Drill biopsy and puncture biopsy for the determination of hormone receptors].

作者信息

Magdelenat H

出版信息

Pathol Biol (Paris). 1983 Nov;31(9):755-60.

PMID:6361673
Abstract

The assays of estrogen (ER) and even more progesterone (PR) receptors are highly required to elaborate the therapeutic strategy adapted to every breast cancer. In order to get this information in the absence of surgery (conservative treatment), three types of tissue sampling are available: drill-biopsy, "thru-cut", and fine needle aspiration. Reliable estimates of ER or PR can be obtained on drill-biopsy or "thru-cut" samples in about 80% of breast tumors measuring more than 2 cm. Fine-needle aspiration allows, up to now, only ER assay, in about 80% of all breast tumors.

摘要

为制定适用于每例乳腺癌的治疗策略，对雌激素（ER）受体甚至孕激素（PR）受体进行检测极为必要。为在不进行手术（保守治疗）的情况下获取此类信息，有三种组织取样方法可供选择：钻孔活检、“穿刺活检”和细针穿刺抽吸。对于直径超过2厘米的约80%的乳腺肿瘤，通过钻孔活检或“穿刺活检”样本可获得可靠的ER或PR检测结果。截至目前，细针穿刺抽吸仅能对约80%的所有乳腺肿瘤进行ER检测。

相似文献

1
[Drill biopsy and puncture biopsy for the determination of hormone receptors].[用于激素受体测定的钻取活检和穿刺活检]
Pathol Biol (Paris). 1983 Nov;31(9):755-60.
2
Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.乳腺癌患者细针穿刺抽吸物中雌激素和孕激素受体的免疫细胞化学检测
Acta Cytol. 1994 Nov-Dec;38(6):933-8.
3
[Contribution of drill-biopsies to pre-treatment investigation of breast adenocarcinomas (author's transl)].
Bull Cancer. 1981;68(5):417-21.
4
Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.细针穿刺抽吸物中乳腺癌雌激素和孕激素受体的免疫细胞化学测定及流式细胞术DNA分析
Anticancer Res. 1993 Nov-Dec;13(6B):2435-40.
5
Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors.
Cancer Res. 1986 Aug;46(8 Suppl):4265s-4267s.
6
Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.在评估浸润性乳腺癌的雌激素受体（ER）、孕激素受体（PR）和人表皮生长因子受体2（HER-2）时，手术标本可用芯针活检样本替代。
Acta Oncol. 2008;47(1):38-46. doi: 10.1080/02841860701441822.
7
[Puncture cytology of the breast: correlation of visual and image analysis studies with hormone receptor status].[乳腺穿刺细胞学：视觉及图像分析研究与激素受体状态的相关性]
Geburtshilfe Frauenheilkd. 1985 Jan;45(1):17-21. doi: 10.1055/s-2008-1036199.
8
Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.219例乳腺癌细针穿刺抽吸物雌激素和孕激素受体的免疫细胞化学测定。一项前瞻性研究。
Anticancer Res. 1995 Mar-Apr;15(2):521-6.
9
[Fine-needle aspiration biopsy and analysis of estrogen receptors in breast cancer].
Bull Cancer. 1982;69(5):456-60.
10
Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?乳腺癌细针穿刺抽吸物及冷冻切片上雌激素和孕激素受体的定量评估：与生化检测相比如何？
East Afr Med J. 1993 May;70(5):280-3.

引用本文的文献

1
Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.纤溶酶原激活物抑制剂-1（PAI-1）与乳腺癌新辅助化疗的反应无关。
Br J Cancer. 1997;76(4):537-40. doi: 10.1038/bjc.1997.421.
2
Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.乳腺癌的基因进化：II. 与雌激素和孕激素受体表达的关系。
Breast Cancer Res Treat. 1992;22(2):119-27. doi: 10.1007/BF01833341.